VANGUARD GROUP INC 13D and 13G filings for Bristol-Myers Squibb Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Sale |
2023-12-29 | 13G | Bristol-Myers Squibb Company BMY |
VANGUARD GROUP INC | 198,155,594 9.740% |
-4,772,026 (-2.35%) |
Filing |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Bristol-Myers Squibb Company BMY |
VANGUARD GROUP INC | 202,927,620 9.540% |
3,093,137 (+1.55%) |
Filing |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Bristol-Myers Squibb Company BMY |
VANGUARD GROUP INC | 199,834,483 9.000% |
494,025 (+0.25%) |
Filing |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Bristol-Myers Squibb Company BMY |
VANGUARD GROUP INC | 199,340,458 8.820% |
4,480,304 (+2.30%) |
Filing |